D-0681-2017 Class II Terminated

Recalled by Isomeric Pharmacy Solution, LLC — Salt Lake City, UT

FDA drug recall D-0681-2017 was initiated by Isomeric Pharmacy Solution, LLC on Apr 6, 2017 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile. The recall status is terminated (terminated Aug 30, 2017). Affected quantity: 4,001 vials.

Recall details

Product Type
Drugs
Report Date
May 3, 2017
Initiation Date
Apr 6, 2017
Termination Date
Aug 30, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,001 vials

Product description

Methylprednisolone Acetate 40 mg/mL, Lidocaine HCl 10 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Drive, SLC, UT 84109, Part # 1010, barcode 3 70285 10101 4.

Reason for recall

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot #s: 09007, Exp 04/04/17; 09016, Exp 04/16/17; 09020, Exp 04/18/17; 09025, Exp 04/23/17; 10026, 10030, Exp 05/28/17; 11007, Exp 05/30/17; 11008, Exp 05/31/17; 11020, Exp 06/07/17; 11028, Exp 06/12/17; 11043, Exp 06/26/17.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0681-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0681-2017. Report a data issue: hello@regdatalab.com.